EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

A Heat-Inactivated Two-Strain Lacticaseibacillus paracasei Fermented Milk as a Postbiotic for Functional Constipation: A Randomized, Double-Blind, Placebo-Controlled Trial

Xinyi Li iD, Hanglian Lan, Yiran Guan, Langrun Wang, Wen Zhao iD, Jian He, Zhi Zhao, Meina Li, Qixu Han, Yifan Gong, Xinxin Yan, Ziwen Li und 3 weitere

Nutrients · 2026

DOI: 10.3390/nu18132114 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2026. Verfasst von Xinyi Li und 14 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Precision Nutrition and Food Quality, Department of Nutrition and Health, China Agricultural University, Beijing 100193, China. Hauptthemen laut MEDLINE: Constipation, Lacticaseibacillus paracasei, Probiotics, Cultured Milk Products. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Association for Science and Technology, National Technology Innovation Center for Dairy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Functional constipation (FC) commonly affects middle-aged and older adults, but current pharmacological treatments have limitations. Postbiotics may offer safety advantages, but clinical evidence is limited. This randomized controlled trial evaluated the efficacy and safety of a heat-inactivated two-strain Lacticaseibacillus paracasei fermented milk in adults with FC.

Methods

One hundred adults aged 45–75 years with Rome IV-defined FC received the fermented milk or placebo for 4 weeks. The primary outcome was the change in weekly spontaneous bowel movement (SBM) frequency from baseline to week 4. Secondary outcomes included complete spontaneous bowel movement (CSBM) frequency, whole-gut transit time (WGTT), constipation symptom scores, quality of life, serum biomarkers, and adverse events. Primary analysis was per-protocol (n = 96); intention-to-treat analysis was applied to primary and key secondary outcomes.

Results

Dropout was 4% (n = 4, 2 per group), and adherence was >80% in both groups. The intervention showed no significant benefit over placebo for the primary outcome or for most secondary clinical outcomes. Although both groups improved within-group, no significant between-group differences were observed at week 4 for changes in SBM (MD = −0.14, 95% CI: −0.85, 0.57; p = 0.683), CSBM (MD = 0.27, 95% CI: −0.61, 1.15; p = 0.543), or WGTT (MD = −1.55 h, 95% CI: −7.65, 4.55; p = 0.614). Symptom and quality-of-life scores also did not differ between groups. Exploratory biomarker analyses showed significantly greater increases in serum VIP and ACh in the intervention group (VIP: MD = 105.23 ng/L, p < 0.001; ACh: MD = 42.95 ng/L, p = 0.035). No adverse events were reported.

Conclusions

Four weeks of this postbiotic was safe but did not significantly improve bowel function or symptoms in the overall FC population. The increases in serum VIP and ACh suggest engagement of neurotransmitter-related pathways; however, these exploratory findings do not imply causation or clinical efficacy and warrant confirmation in longer-duration trials (Clinical Trial Registry: ChiCTR2500111771).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ConstipationLacticaseibacillus paracaseiProbioticsCultured Milk ProductsHumansDouble-Blind MethodMiddle AgedFemaleAgedMaleTreatment OutcomeHot TemperatureQuality of LifeAnimalsGastrointestinal TransitBiomarkers

Stichwörter der Autor:innen

acetylcholinefunctional constipationheat-inactivated Lacticaseibacillus paracaseirandomized controlled trialvasoactive intestinal peptide

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Key Laboratory of Precision Nutrition and Food Quality, Department of Nutrition and Health, China Agricultural University, Beijing 100193, China.
  • National Technology Innovation Center for Dairy, Hohhot 010100, China.
  • School of Food and Health, Beijing Technology and Business University, Beijing 100048, China.
  • Research Center for Probiotics, China Agricultural University, Beijing 100190, China.

ORCID-Profile: Xinyi Li, Wen Zhao, Jingjing He

Förderung

  • China Association for Science and Technology
  • National Technology Innovation Center for Dairy

Zitieren

APA

Li, X., Lan, H., Guan, Y., Wang, L., Zhao, W., He, J., Zhao, Z., Li, M., Han, Q., Gong, Y., Yan, X., Li, Z., Guo, J., Wang, R., & He, J. (2026). A Heat-Inactivated Two-Strain Lacticaseibacillus paracasei Fermented Milk as a Postbiotic for Functional Constipation: A Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients. https://doi.org/10.3390/nu18132114

Vancouver

Li X, Lan H, Guan Y, Wang L, Zhao W, He J, et al. A Heat-Inactivated Two-Strain Lacticaseibacillus paracasei Fermented Milk as a Postbiotic for Functional Constipation: A Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients. 2026. doi:10.3390/nu18132114

BibTeX
@article{Li2026,
  author = {Li, Xinyi and Lan, Hanglian and Guan, Yiran and Wang, Langrun and Zhao, Wen and He, Jian and Zhao, Zhi and Li, Meina and Han, Qixu and Gong, Yifan and Yan, Xinxin and Li, Ziwen and Guo, Jie and Wang, Ran and He, Jingjing},
  title = {A Heat-Inactivated Two-Strain Lacticaseibacillus paracasei Fermented Milk as a Postbiotic for Functional Constipation: A Randomized, Double-Blind, Placebo-Controlled Trial},
  journal = {Nutrients},
  year = {2026},
  doi = {10.3390/nu18132114}
}
Kostenlos starten →